Tirzepatide and Warfarin: Can You Take Them Together?

Moderate: Timing MattersAbsorption
Learn about each ingredient:TirzepatideWarfarin

Quick answer

Tirzepatide (Mounjaro, Zepbound) slows how fast the stomach empties, most after the first dose, which can change how pills taken by mouth are absorbed. The Mounjaro and Zepbound labels name warfarin as a medicine to monitor, because small changes in its level matter. Neither label reports a warfarin study. Two case reports describe INR changes after tirzepatide was started or increased, one falling and one rising, and neither proves cause.

If you take warfarin, tell the person who manages your INR when tirzepatide is started or its dose goes up, because they may want to check your INR more often. Do not change your warfarin dose on your own, and report unusual bleeding or bruising.

Taking more than these two?Check your whole list for interactions. Free, no account.

What happens?

Tirzepatide does not act on clotting, but it slows the stomach. That can change how pills such as warfarin are absorbed.

1

Slower stomach

Tirzepatide delays gastric emptying, most after the first dose; the effect fades over time.

2

Absorption may change

A slower stomach can change how warfarin tablets are absorbed.

3

Narrow safety range

Small changes in warfarin's level can push the INR too high or too low.

After a first dose, tirzepatide cut the peak level of a test drug by <strong>50 to 55%</strong>; the effect fades over <strong>several weeks</strong> of treatment.

Why is this important?

Warfarin has a narrow safety range, so even small changes in absorption can move the INR.

Bleeding or clots

A high INR raises bleeding risk; a low INR raises the risk of stroke or a clot, especially with a mechanical heart valve.

Case reports

Two case reports describe INR changes after starting or increasing tirzepatide, one falling and one rising; neither proves cause.

Diet changes

Eating much less can change vitamin K intake, which can also move the INR.

The evidence is thin, so the labels ask for monitoring rather than avoidance.

What should you do?

The practical fix is simple: separate the doses.

Tell whoever manages your INR when tirzepatide is started or increased

Best practical schedule

Before starting tirzepatide
Tell your prescriber and your anticoagulation clinic; they may plan extra INR checks.
After each dose increase
Ask whether an extra INR check is needed, and mention big changes in how much you eat.
Every day
Take warfarin exactly as prescribed and never change the dose on your own.

Important reminders

  • •Tirzepatide does not thin the blood; the concern is absorption and diet changes.
  • •The stomach-slowing effect is largest after the first dose and fades over time.
  • •Report unusual bleeding, bruising, or black or bloody stools.
  • •Get emergency care for signs of a stroke or a clot.

Studies of semaglutide and dulaglutide found no clinically relevant warfarin effect in healthy volunteers, but tirzepatide has not been studied with warfarin.

Which specific products are affected?

Many common Warfarin products can affect this interaction.

Tirzepatide products

Mounjaro (tirzepatide) pens and vialsZepbound (tirzepatide) pens and vials

Warfarin products

Jantoven (warfarin)Generic warfarin tabletsCoumadin (older brand name)

Other sources

  • •The labels give the same monitoring advice for other oral medicines that need steady levels.

This applies whenever tirzepatide is started or its dose is increased; tell everyone who manages your warfarin.

The bottom line

Tirzepatide slows how fast the stomach empties, which can change how warfarin tablets are absorbed, and the Mounjaro and Zepbound labels name warfarin as a medicine to monitor. No warfarin study is on the labels, and two case reports describe INR changes in opposite directions. Tell whoever manages your INR when tirzepatide is started or increased.

Never change your warfarin dose on your own; your clinician decides based on your INR.

What happens when you take tirzepatide with warfarin?

Tirzepatide is a weekly injection: Mounjaro for blood sugar control in type 2 diabetes, and Zepbound for weight loss and for obstructive sleep apnea in adults with obesity. Warfarin (Jantoven and generics) is a blood thinner with a narrow safety range, checked with the INR blood test. Tirzepatide does not act on clotting, but it slows the stomach, which can change how warfarin tablets are absorbed.

  1. Tirzepatide slows the stomach. The labels say tirzepatide delays gastric emptying, most after the first dose, and the effect fades over time.
  2. Pill absorption can change. A slower stomach can change how fast or how much of an oral medicine is absorbed.
  3. Warfarin has little room for error. Small changes in warfarin's level can push the INR too high (bleeding risk) or too low (clot risk).
  4. Eating less matters too. Tirzepatide often reduces appetite, and big changes in diet, including vitamin K intake, can also move the INR.

Why is this important?

Both tirzepatide labels tell prescribers to monitor people on oral medicines with a narrow therapeutic index, and they give warfarin as the example. An INR that drifts too high raises the risk of bleeding; one that drifts too low raises the risk of stroke or a clot, which matters most for people with a mechanical heart valve or a past clot.

The evidence so far is thin. No warfarin study is reported on either label. Two case reports describe INR changes after tirzepatide: in one, a woman with a mechanical heart valve had a marked drop in INR 10 days after starting it; in the other, a man had an INR of 8.7 after a dose increase, alongside other serious illness. Studies of two other GLP-1 medicines, semaglutide and dulaglutide, in healthy volunteers found no clinically relevant change in warfarin's effect. So the risk is real enough to monitor, but how often it happens is unknown.

What should you do?

Before starting tirzepatide: Tell your prescriber and the person who manages your warfarin. They may plan extra INR checks for the first weeks.

After each dose increase: The labels say the stomach-slowing effect is largest after the first dose and fades over time, and their birth control advice covers the 4 weeks after each dose increase as well. Ask whether an extra INR check is useful after an increase, and mention big changes in how much you eat, too.

Every day: Take warfarin exactly as prescribed and never change the dose on your own. Get medical help for unusual bleeding or bruising, black or bloody stools, blood in the urine, or signs of a stroke or clot.

Which specific products are affected?

On the tirzepatide side: Mounjaro and Zepbound, in pens and vials. On the warfarin side: Jantoven and generic warfarin tablets (Coumadin is the older brand name).

The same label advice covers other oral medicines that need steady levels, but this page is about warfarin. Other GLP-1 medicines have their own labels and studies.

The science behind it

The Mounjaro prescribing information (DailyMed, section 7.2) says Mounjaro delays gastric emptying and thereby has the potential to impact the absorption of oral medications, and tells prescribers to "monitor patients on oral medications dependent on threshold concentrations for efficacy and those with a narrow therapeutic index (e.g., warfarin)." The Zepbound label (DailyMed, section 7.2) says the same. In label studies, a first dose of tirzepatide reduced the peak level of acetaminophen, a test drug for stomach emptying, by 50% (Mounjaro) to 55% (Zepbound) without changing total exposure, and the effect was gone after several weeks of treatment.

Two case reports point to a possible effect on INR. Natale R, et al. (Eur J Case Rep Intern Med. 2025; PMID 41064709) describe a 66-year-old woman with a mechanical mitral valve whose INR fell markedly 10 days after starting tirzepatide despite a stable diet; reaching her target took about three weeks of warfarin increases. Shakour H, et al. (Cureus. 2025; PMID 40225446) describe a 64-year-old man on warfarin whose INR was 8.7 after a tirzepatide dose increase; he also had vasculitis and kidney injury, so the cause is unclear.

Studies with other GLP-1 medicines did not show a clinically relevant warfarin effect in healthy volunteers: Hausner H, et al. (Clin Pharmacokinet. 2017; PMID 28349387) for injected semaglutide, and de la Pena A, et al. (Clin Pharmacokinet. 2017; PMID 28357715) for dulaglutide.

What was not shown: no controlled study has tested tirzepatide with warfarin, and two case reports are a signal, not proof.

Frequently Asked Questions

Can I take Mounjaro or Zepbound with warfarin?

Yes, many people do, but the labels say to monitor. Ask the person who manages your warfarin whether you need extra INR checks.

Does tirzepatide thin the blood?

No. It does not act on clotting. The concern is that it may change how warfarin is absorbed, and that eating much less can change your vitamin K intake.

When is the risk highest?

The labels say the stomach-slowing effect is largest after the first dose and fades over time; their birth control advice also covers the weeks after each dose increase. Starting tirzepatide and each dose increase are the times to ask about extra INR checks.

Should I change my warfarin dose when I start tirzepatide?

Never change it on your own. Your clinician decides based on your INR results.

What signs should I watch for?

Unusual bruising or bleeding, black or bloody stools, or blood in the urine can mean the INR is too high. Sudden weakness, trouble speaking, or a swollen painful leg can mean a clot. Get medical help right away for any of these.

Key takeaways

  • Tirzepatide slows stomach emptying, which can change how warfarin tablets are absorbed.
  • The Mounjaro and Zepbound labels name warfarin as a medicine to monitor.
  • No warfarin study is on the labels; two case reports describe INR changes in opposite directions.
  • The effect is largest after the first dose, so starting tirzepatide and each dose increase are the times to ask about extra INR checks.
  • Never change your warfarin dose on your own; report bleeding or bruising.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Tirzepatide + Oral Contraceptives (including Progestin-Only Pills)

high

Tirzepatide slows how quickly the stomach empties, and that slowing is strongest right after the first dose and after each dose increase. A birth control pill relies on being absorbed promptly and completely; when the stomach holds onto it, peak hormone levels fall by more than half. The FDA label instructs patients on oral hormonal contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and for four weeks after every dose increase. Contraceptives that are not swallowed are not affected.

Semaglutide + Psyllium

moderate

Semaglutide slows how fast the stomach empties. In one endoscopy series of 100 people before weight-loss surgery, 4 of 23 taking a GLP-1 medicine had a gastric bezoar (a solid mass of undigested material) 4 cm or larger, against none of 77 not taking one (the drugs named were liraglutide and semaglutide); all four cleared after the medicine was stopped. Separate case reports describe blockages from psyllium bezoars, and slow stomach emptying is a known risk factor. No study has tested psyllium with semaglutide, so the combined risk is not known. Bulk fiber also swells with water and can block the throat if taken with too little fluid.

Tirzepatide + Glipizide

high

Tirzepatide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. a sulfonylurea such as glipizide does not work that way; it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Tirzepatide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.

Tirzepatide + Thiamine

high

This is not a direct drug interaction. Tirzepatide reduces appetite and can cause long-lasting nausea or vomiting, and if food intake stays very low for weeks, the body can run short of thiamine (vitamin B1). Severe shortage causes Wernicke encephalopathy: confusion, unsteady walking and abnormal eye movements. Early treatment with thiamine given by vein is needed to prevent lasting damage. A 2026 study of the FDA adverse event database and the literature found 15 cases linked to GLP-1 medicines, 6 of them with tirzepatide, and a 2026 case report describes lasting memory loss (Korsakoff syndrome) in a man with alcohol use disorder who lost weight rapidly within weeks of starting tirzepatide.

Liraglutide + Psyllium

moderate

Liraglutide slows how fast the stomach empties. In one endoscopy series of 100 people before weight-loss surgery, 4 of 23 taking a GLP-1 medicine had a gastric bezoar (a solid mass of undigested material) 4 cm or larger, against none of 77 not taking one (the drugs named were liraglutide and semaglutide); all four cleared after the medicine was stopped. Separate case reports describe blockages from psyllium bezoars, and slow stomach emptying is a known risk factor. No study has tested psyllium with liraglutide, so the combined risk is not known. Bulk fiber also swells with water and can block the throat if taken with too little fluid.

Pumpkin Seeds + Warfarin

low

Pumpkin seeds (pepitas) are not a leafy green, and no published study or case report links them to INR changes on warfarin. The warfarin label's general rule still applies: keep your overall vitamin K intake consistent and avoid drastic changes in diet.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free